BioNexus Gene Lab Corp. (BGLC)

NCM – Real Time Price. Currency in USD

1.59

+0.07 (4.61%)

Market open: Aug 12, 2026, 9:53 AM EDT

1.52

0.00 (0.00%)

Previous after-hours: Aug 11, 2026, 7:34 PM EDT

Summary
News
Chart
Financial
Dividends
Forecast
Ownership
Profile

Revenue

Gross Profit

Operating Income

Net Income

Income Statement
Balance Sheet
Cash Flow

Income Statement (Annual)

Financials in millions USD. Fiscal year is January – December.

Name

2025

2024

2023

2022

Total Revenue

10M

11M

Cost of goods sold

-6M

-8M

-9M

-10M

Gross Profit

973K

Operating expenses (excl. COGS)

-4M

-3M

-4M

-2M

Operating Income

-3M

-2M

-3M

-470K

Non-operating income, total

174K

362K

472K

167K

Pretax income

-3M

-2M

-3M

-304K

Equity in earnings

Taxes

-3K

-22K

-52K

Non-controlling/minority interest

After tax other income/expense

Net income before discontinued operations

-3M

-2M

-3M

-356K

Discontinued operations

Net income

-3M

-2M

-3M

-356K

Dilution adjustment

Preferred dividends

BioNexus Gene Lab Corp. (BGLC)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

BioNexus Gene Lab Corp. (BGLC)

Income Statement (Annual)

Income Statement (Annual)

Search stocks

BioNexus Gene Lab Corp. (BGLC)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

BioNexus Gene Lab Corp. (BGLC)

Income Statement (Annual)

Income Statement (Annual)